Understanding of the precise molecular events underpinning the role of hMSH5 in harnessing NHEJ will provide an opportunity to manipulate DSB repair in cancer cells, thereby enhancing the therapeutic efficacy of DSB-inducing anticancer treatments. The gene discussed is MSH5; the disease is cancer.